Ojala Laboratory (@piviojala4) 's Twitter Profile
Ojala Laboratory

@piviojala4

Cancer cell biology and oncogenic viruses

ID: 1184413435188125697

linkhttps://www.helsinki.fi/en/researchgroups/cancer-cell-biology calendar_today16-10-2019 10:19:41

15 Tweet

93 Followers

80 Following

Lehti Lab (@lehtilab) 's Twitter Profile Photo

We are happy to be hosting Pirjo Laakkonen & Ojala Laboratory for two very interesting seminars tomorrow Karolinska Institutet . More info here 👉 news.ki.se/extra-seminar-… Biomedicum A0315, 12:30 👉 news.ki.se/extra-seminar-… Biomedicum D1012 (meet at A0315, 13.40)

Ojala Laboratory (@piviojala4) 's Twitter Profile Photo

Accepted manuscript to JVI now published for fresh reading; Kaposi sarcoma herpesvirus lytic replication is independent of the anaphase promoting complex activity. Congratulations to E. Elbasani and contributors! #KSHV jvi.asm.org/content/early/…

Ojala Laboratory (@piviojala4) 's Twitter Profile Photo

What is the molecular etiology of the spontaneous lytic phase observed in KSHV-infected primary human lymphatic endothelial cells? See our article, published today in Cancer Research! Congratulations to authors, especially to Silvia Gramolelli🥳👏 cancerres.aacrjournals.org/content/early/…

Medicine and Health, University of Helsinki (@helsinkiunimed) 's Twitter Profile Photo

Virusperäisen Kaposin sarkooma -syövän (KS) taustatekijöistä on saatu uutta tietoa. Keskeisten proteiinien toimintamekanismien ymmärtäminen auttaa uusien hoitomuotojen kehityksessä sairauteen. University of Helsinki #HelsinkiHealth helsinki.fi/fi/uutiset/ter…

Ojala Laboratory (@piviojala4) 's Twitter Profile Photo

We are most grateful to Sigrid Jusélius Stiftelse for funding (2021-26) the research collaboration of Professors Päivi Ojala and Sirpa Leppä University of Helsinki HUS Helsingin yliopistollinen sairaala Comprehensive Cancer Center to advance CAR-T cell therapy for haematological and solid cancers. #sigridjuseliusfoundation 🥳

Ojala Laboratory (@piviojala4) 's Twitter Profile Photo

We wish to thank Finnish Red Cross #Veripalvelu for the grant to develop efficient and safe Chimeric Antigen Receptor (CAR) T‐cell therapy for haematological and solid cancers 🩸♥️

Ojala Laboratory (@piviojala4) 's Twitter Profile Photo

We are happy to announce that our study carried out with Prof Sirpa Leppä Lab on CAR-T cell therapy is now published in Molecular Cancer Therapeutics 🥳 pubmed.ncbi.nlm.nih.gov/37486980/

Ojala Laboratory (@piviojala4) 's Twitter Profile Photo

Very happy to share our new publication JCI insight, on the crosstalk between melanoma and LECs in melanoma metastasis. pubmed.ncbi.nlm.nih.gov/37971882/